Post by masders on Feb 15, 2024 2:47:39 GMT -6
During the last years, the number of patients affected by cancer has increased and continues to increase significantly. According to data from the World Health Organization and the International Agency for Research on Cancer, 12 million people worldwide have been diagnosed with a certain type of cancer. By 2030, this number is expected to increase to 26 million. With the increase in the number of people affected by cancer, the number of successfully treated cases has also increased. The quality of life of these patients has been improved by chemotherapy and radiation therapy. As a result of the development of medical technology, significant improvement of cancer has been achieved by means of radiotherapy.
One of the newest generations in radiotherapy is Tunisia Email List TRILOGY. Dr. Deva Petrova, radiation oncologist at the "Acibadem Sistina" clinical hospital, explains what TRILOGY is. What is the advantage of TRILOGY? TRILOGY is a linear accelerator of radiation therapy against the tumor, with a small volume and providing at the same time a maximum protection of the surrounding healthy tissues. It is used for successful treatment of all types of solid tumors, as well as certain hematological types such as lymphomas. The TRILOGY system allows the implementation of the IGRT standard and can be used to implement three-dimensional conformal radiotherapy (3D CRT), intensity modulated radiotherapy (IMRT), stereotaxic radiotherapy and fractionated stereotaxic radiotherapy. Is radiation time shortened as a result of these advantages? With the TRILOGY accelerator, the radiation dose can be delivered 60% faster than conventional linear accelerators, which means that patient treatment is significantly shortened.
Conventional radiotherapy is applied for several weeks, in small doses. With TRILOGY, the oncologist can treat tumors using stereotaxic radiotherapy, which means high daily doses, and overall treatment duration of several days. For what types of treatment is it recommended? With the help of Trilogy, computed tomography СВСТ can be done during the treatment period, which enables accurate control during the treatment. This is very important for tumors that are found in mobile organs such as lungs, prostate, liver, etc. Also, the Trilogy technology enables tumor monitoring during treatment. In case the tumor shrinks significantly, this can be seen and in this way the radiation field reduction plan can be adapted according to the size of the tumor, with maximum protection of other healthy organs.
One of the newest generations in radiotherapy is Tunisia Email List TRILOGY. Dr. Deva Petrova, radiation oncologist at the "Acibadem Sistina" clinical hospital, explains what TRILOGY is. What is the advantage of TRILOGY? TRILOGY is a linear accelerator of radiation therapy against the tumor, with a small volume and providing at the same time a maximum protection of the surrounding healthy tissues. It is used for successful treatment of all types of solid tumors, as well as certain hematological types such as lymphomas. The TRILOGY system allows the implementation of the IGRT standard and can be used to implement three-dimensional conformal radiotherapy (3D CRT), intensity modulated radiotherapy (IMRT), stereotaxic radiotherapy and fractionated stereotaxic radiotherapy. Is radiation time shortened as a result of these advantages? With the TRILOGY accelerator, the radiation dose can be delivered 60% faster than conventional linear accelerators, which means that patient treatment is significantly shortened.
Conventional radiotherapy is applied for several weeks, in small doses. With TRILOGY, the oncologist can treat tumors using stereotaxic radiotherapy, which means high daily doses, and overall treatment duration of several days. For what types of treatment is it recommended? With the help of Trilogy, computed tomography СВСТ can be done during the treatment period, which enables accurate control during the treatment. This is very important for tumors that are found in mobile organs such as lungs, prostate, liver, etc. Also, the Trilogy technology enables tumor monitoring during treatment. In case the tumor shrinks significantly, this can be seen and in this way the radiation field reduction plan can be adapted according to the size of the tumor, with maximum protection of other healthy organs.